Kim PngPartner at Novo HoldingsSpeaker
Profile
Kim Png is a Partner at Novo Holdings, based in Singapore, where she focuses on biotech venture investments, with an emphasis on novel biology platforms and cross-border opportunities across Asia-Pacific.
Prior to joining Novo Holdings, Kim was with Polaris Partners, where she established the firm's Singapore office and managed a portfolio of biotech companies across the US, Europe, and Singapore. She was previously with Temasek's Life Sciences Investment Group, where she invested across private and public biotechnology companies globally and played a founding role in ClavystBio, Temasek's life sciences investment and venture-building platform.
Kim holds a PhD in Biomedical Sciences from Rockefeller University, a Master of Business Administration from Singapore Management University, and a BSE in Biomedical Engineering from Duke University.
Agenda Sessions
Asia’s Biotech Boom: Unlocking Potential Through Innovation and Strategic Partnerships
, 15:00View Session
